Iodine API Manufacturers
compare suppliers & get competitive offers
Join our notification list by following this page.
Click the button below to find out more
Click the button below to switch over to the contract services area of Pharmaoffer.
Looking for Iodine API 7553-56-2?
- Description:
- Here you will find a list of producers, manufacturers and distributors of Iodine. You can filter on certificates such as GMP, FDA, CEP, Written Confirmation and more. Send inquiries for free and get in direct contact with the supplier of your choice.
- API | Excipient name:
- Iodine
- Synonyms:
- diiodine , I2 , iodo , Jod , molecular iodine
- Cas Number:
- 7553-56-2
- DrugBank number:
- DB05382
- Unique Ingredient Identifier:
- 9679TC07X4
General Description:
Iodine, identified by CAS number 7553-56-2, is a notable compound with significant therapeutic applications. Iodine is commonly used as an antiseptic for minor cuts and abrasions, preventing infections that may result from contaminated wounds. Additionally, iodine has been studied in the treatment of fibrocystic disease and breast cancer.
Indications:
This drug is primarily indicated for: Investigated for use/treatment in breast disorders (unspecified) and pain (acute or chronic). Its use in specific medical scenarios underscores its importance in the therapeutic landscape.
Mechanism of Action:
Iodine functions by: Molecular iodine is known to inhibit the induction and promotion of N-methyl-n-nitrosourea-induced mammary carcinogenesis, to regress 7,12-dimethylbenz(a)anthracene-induced breast tumors in rats.It has also been shown to have beneficial effects in fibrocystic human breast disease. This mechanism highlights the drug's role in inhibiting or promoting specific biological pathways, contributing to its therapeutic effects.
Classification:
Iodine belongs to the class of inorganic compounds known as homogeneous halogens. These are inorganic non-metallic compounds in which the largest atom is a nobel gas, classified under the direct parent group Homogeneous halogens. This compound is a part of the Inorganic compounds, falling under the Homogeneous non-metal compounds superclass, and categorized within the Homogeneous halogens class, specifically within the None subclass.
Categories:
Iodine is categorized under the following therapeutic classes: Anti-Infective Agents, Anti-Infective Agents, Local, Antiseptics and Disinfectants, Dermatologicals, Diet, Food, and Nutrition, Elements, Food, Growth Substances, Halogens, Herbs and Natural Products, Iodine Products, Micronutrients, Minerals, Miscellaneous Local Anti-infectives, Trace Elements. These classifications highlight the drug's diverse therapeutic applications and its importance in treating various conditions.
Iodine is a type of Anti-infective Agents
Anti-infective agents are a vital category of pharmaceutical active pharmaceutical ingredients (APIs) used in the treatment of various infectious diseases. These agents play a crucial role in combating bacterial, viral, fungal, and parasitic infections. The demand for effective anti-infective APIs has grown significantly due to the increasing prevalence of drug-resistant microorganisms.
Anti-infective APIs encompass a wide range of substances, including antibiotics, antivirals, antifungals, and antiparasitics. Antibiotics are particularly important in fighting bacterial infections and are further categorized into different classes based on their mode of action and target bacteria. Antivirals are designed to inhibit viral replication and are essential in the treatment of viral infections such as influenza and HIV. Antifungals combat fungal infections, while antiparasitics are used to eliminate parasites that cause diseases like malaria and helminthiasis.
The development and production of high-quality anti-infective APIs require stringent manufacturing processes and adherence to regulatory standards. Pharmaceutical companies invest heavily in research and development to discover new and more effective anti-infective agents. Additionally, ensuring the safety, efficacy, and stability of these APIs is of utmost importance.
The global market for anti-infective APIs is driven by factors such as the rising incidence of infectious diseases, the emergence of new and drug-resistant pathogens, and the growing demand for improved healthcare infrastructure. Continuous advancements in pharmaceutical technology and the development of innovative drug delivery systems further contribute to the expansion of this market.
In conclusion, anti-infective agents are a critical category of pharmaceutical APIs that play a pivotal role in treating infectious diseases. Their effectiveness in combating various types of infections makes them essential components in the arsenal of modern medicine.
